EASL Studio Podcast: YI Choice: Gene therapy for liver disease — RNA interference and beyond

EASL Podcasts - A podcast by European Association for the Study of the Liver

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Emerging therapeutics based on gene addition, editing, or silencing are expected to change the landscape of genetic liver disease.Watch this episode to find out:Which approaches exist?Where are they in terms of preclinical and clinical development?How will they be used?FacultyDr Mattias Mandorfer (Moderator)Dr Gloria Gonzalez-Aseguinolaza (Faculty)Prof. Pavel Strnad (Faculty)Prof. Man-Fung Yuen (Faculty)All EASL Studio Podcasts are available on EASL Campus.